Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Therapeutic Efficacy of Lamivudine in Patients With Hepatitis B Virus-Related Decompensated Cirrhosis in Korea

Saera Jung, M.D., Dong Jin Suh, M.D., Hyun Ju Park, M.D., Young Hwan Park, M.D. Hee Gon Song, M.D., Han Chu Lee, M.D., Young-Hwa Chung, M.D. and Yung Sang Lee, M.D.

Clin Mol Hepatol. 2002;8(4):418-427. Published online January 1, 2000

View: 3096 Download: 17

Relationship Between Core Gene Mutations of Hepatitis B Virus and Response to Alpha Interferon Therapy in Chronic Hepatitis B

Byung Chul Yoo , Hyung Joon Kim , Jae Hyuk Do , Sill Moo Park

Clin Mol Hepatol. 2002;8(4):381-388. Published online January 1, 1970

View: 2639 Download: 29

Gene Expression Profile in Response to Hepatitis B Virus X Gene by Using an Adenoviral Vector

Heui Yun Joo, M.S., Kwang Hyub Han, M.D.*, Wang Shick Ryu, Ph.D†

Clin Mol Hepatol. 2002;8(4):371-380. Published online January 1, 1970

View: 2942 Download: 28

The Clinical Significance of Quantitation of HBV DNA in Serum : Comparison of the Branched-DNA Assay with the Second-Generation Digene Hybrid Capture Assay and Long-term Observation

Eun Jung Jun, M.D., Joon-Yeol Han, M.D., Hwang Choi, M.D., U Im Chang, M.D., Tae Kyu Lee, M.D., Young Hwan Kim, M.D., Jin Il Kim, M.D., Soo Heon Park, M.D., Jae Kwang Kim, M.D., Kyu Won Chung, M.D. and Hee Sik Sun, M.D.

Clin Mol Hepatol. 2002;8(2):157-166. Published online January 1, 2000

View: 2515 Download: 20

The Prevalence and Clinical Significance of Precore and Core Promoter Mutations in Korean Patients with Chronic Hepatitis B Virus Infection

Hyung Joon Kim,Byung Chul Yoo

Clin Mol Hepatol. 2002;8(2):149-156. Published online January 1, 1970

View: 3381 Download: 27

Clinical Characteristics of Non - B , Non - C Hepatocellular Carcinoma and Detection of HBV , HCV and TTV Viremia

Hyun Ho Cho, Young Ho Kim, Jin Mo Jung, Kwang Hee Cho, Sang &#;Hyung Cho, Dae Hyun Choi, Sook-Hyang Jeong, Jin-Hyuk Lee, Chul Ju Han, You Cheoul Kim, Jhin Oh Lee, and Chang &#;Min Kim*

Clin Mol Hepatol. 2001;7(4):439-448. Published online January 1, 1970

View: 3115 Download: 16

Prevalence of HBV Genotypes in Korean Patients with Chronic Hepatitis B

Il Hyun Cho,Jung Youp Song,Deog Ki Kim,Hong Seok Lim,Seung Soo Sheen,Won Seok Kim,Kee Myeong Lee,Ki Baik Hahm,Jin Hong Kim,Sung Won Cho

Clin Mol Hepatol. 2001;7(4):381-386. Published online January 1, 1970

View: 3345 Download: 35

Efficacy of Lamivudine in Patients with HBeAg-Negative and HBV DNA-Positive Chronic Liver Disease

Hye Seung Yoo,Han Joo Lee,Young Hwa Jung,Young Sang Lee,Dong Jin Seo

Clin Mol Hepatol. 2000;6(4):488-494. Published online January 1, 2000

View: 2506 Download: 13

A Prospective Study of Therapeutic Effect of 6 Months Trial with Lamivudine in Patients with Chronic Viral Hepatitis B

Chang Woo Gham,Soong Hwan Lee,Seung Woo Nam,Seung Woo Nam,Byung Joo Roh,Dong Hoo Lee

Clin Mol Hepatol. 1999;5(4):282-290. Published online January 1, 2000

View: 2529 Download: 11

Hepatitis B and C Virus in Hepatocellular Carcinoma

Young Soo Kim, Kwang Jae Lee, Young Soo Moon, Ki Baek Hahm, Jin Hong Kim, Sung Won Cho, Sang In Lee, Chan Sup Shim*

Clin Mol Hepatol. 1996;2(1):61-67. Published online January 1, 2000

View: 9417 Download: 20

Comparison of the Incidence of Hepatocellular Carcinoma in HBV - and HCV - associated Liver Cirrhosis ; A Prospective Study

Hyo Suk lee , Jun Haeng Lee , Moon Suk Choi , Chung Yong kim

Clin Mol Hepatol. 1996;2(1):21-28.

View: 2608 Download: 14

Editorial

Regulation of Hepatitis B Virus cccDNA by Metabolic Pathways

Hyeong-Jin Cho, Sung-Gyoo Park

Received March 4, 2025 Accepted March 9, 2025

DOI: https://doi.org/10.3350/cmh.2025.0255 [Accepted]

View: 558 Download: 56 Crossref: 1

Viral manipulation of host cell glutamine metabolism and glutamine rewiring in hepatic diseases: Editorial on “GDH1-dependent α-ketoglutarate promotes HBV transcription by modulating histone methylations on the cccDNA minichromosome”

Mehrangiz Dezhbord, Kyun-Hwan Kim

Received April 2, 2025 Accepted April 8, 2025

DOI: https://doi.org/10.3350/cmh.2025.0366 [Accepted]

View: 383 Download: 49

1 | 2 | 3 | 4 |

Viewed By 12380	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7576	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 7010	MAFLD: How is it different from NAFLD?
Viewed By 5631	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5462	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 366	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 348	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search